The Omicron subvariant JN.1 has been identified in at least 37 US states and is now dominant, accounting for an estimated 44% of COVID-19 cases as of December 18th, a significant increase from just 7.5% in November. However, the Centers for Disease Control and Prevention (CDC) states that JN.1 does not present a higher public health risk than other variants.
Debunked Episode 25: Sutter Health’s Allina Health Acquisition Strategy, a Deep Dive on Doctronic
In the latest episode of the Debunked podcast, MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, discussed recent M&A
